Vaccines

dsc0336

Asia vaccine strategists call for collaboration

  • Singapore
  • |
  • News

Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international players, local research institutes and government... Read more

mers-virus-infecting-middle-east

MERS coronavirus kills four more in Saudi


  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The Saudi Arabia Health Ministry on Monday confirmed four more deaths from the new SARS-like coronavirus MERS-CoV.... Read more

bad-news-for-flu-virus-sanofi-pasteur-s-fluzone-quadrivalent-flu-vaccine-gets-us-fda-nod

FDA nod for Sanofi quadrivalent flu vaccine


  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain influenza... Read more

singaporeans-should-get-vaccinated-to-prevent-hepatitis-a-during-travel-to-infectious-areas

Singaporean travelers highly prone to Hepatitis A

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A study conducted in Singapore has revealed that people, who travel to high risk areas associated with infectious diseases,... Read more

eu-member-states-have-halted-the-use-of-novatis-anti-influenza-vaccine-as-a-precautionary-measure-due-to-a-suspected-quality-defect

Quality issues get Novartis vaccine in trouble in EU

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A number of European Union (EU) member states have halted the use, as a precautionary measure, of some anti-influenza vaccines... Read more

seasonal-influenza-boosts-vaccines-market

Influenza can get worse with every season

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Acute viral respiratory infection influenza, or flu, strikes every winter, and several nations are preparing to tackle this illness... Read more

you-can-run-but-you-cannot-hide-biodiem-develops-broad-spectrum-antimicrobial-compound-bdm-i

Biodiem develops killer for drug-resistant microbes

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial compound with broad-spectrum... Read more

envirotainer-ceo-gustaf-ljunggren

Big potential in Asia market: Envirotainer CEO

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

According to industry estimates, healthcare cold-chain market is growing by 10 percent per year since companies producing blood plasma,... Read more

Biotech-310x175_copy

Director of Chinese firm Simcere resigns

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mr Gary Siu Kwan Sik, an independent director of China-based Simcere Pharmaceutical, has resigned, effective October 11, 2012.... Read more

vaccine-program-pakistan

GSK pneumococcal vaccine to be introduced in Pakistan

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A pneumococcal vaccine, Synflorix, by GlaxoSmithKline will be be introduced into the national immunization program in Pakistan.... Read more

vaccine-gsk-aeras

Aeras signs deal with GSK to develop TB vaccine

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aeras, a not-for-profit fully integrated tuberculosis vaccine development organization, has signed an agreement with GlaxoSmithKline... Read more

david-hoey-vaxxas

Vaxxas appoints David Hoey as CEO

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Vaxxas, a biotechnology company commercializing a novel vaccine-delivery platform that activates immunological cells immediately... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X